Expression of functional human C1 inhibitor in COS cells
- PMID: 2841334
Expression of functional human C1 inhibitor in COS cells
Abstract
Full length human C1 inhibitor cDNA was cloned into a vector suitable for transient expression in COS-1 cells. Transfected COS cells secreted an immunoreactive protein of Mr approximately 110,000 that appeared to be functionally equivalent to the plasma-derived protein as established by the following criteria: 1) ability to form sodium dodecyl sulfate-stable complexes with C1s, factor XIIa, and kallikrein; 2) inhibition of C1s-mediated C4 consumption; and 3) susceptibility to inactivation by the nontarget proteinase elastase. Quantitation of secreted recombinant C1 inhibitor by radioimmunoassay indicated that 72 h after transfection the level was approximately 2.2 micrograms/ml. Treatment of transfected cells with tunicamycin resulted in secretion of a protein of Mr approximately 90,000 that was also capable of complex formation with C1s.
Similar articles
-
A common neoepitope is created when the reactive center of C1-inhibitor is cleaved by plasma kallikrein, activated factor XII fragment, C1 esterase, or neutrophil elastase.J Clin Invest. 1988 Aug;82(2):700-5. doi: 10.1172/JCI113650. J Clin Invest. 1988. PMID: 2457036 Free PMC article.
-
The balance between inhibition and substrate-type reactions of recombinant C1 inhibitor P5/P3 variants.Behring Inst Mitt. 1993 Dec;(93):125-30. Behring Inst Mitt. 1993. PMID: 8172559 No abstract available.
-
Characterization of recombinant C1 inhibitor P1 variants.J Biol Chem. 1992 Apr 5;267(10):7013-20. J Biol Chem. 1992. PMID: 1551909
-
Major inhibitors of the contact phase coagulation factors.Semin Thromb Hemost. 1987 Jan;13(1):69-78. doi: 10.1055/s-2007-1003476. Semin Thromb Hemost. 1987. PMID: 2436302 Review. No abstract available.
-
Pathogenic mechanisms of bradykinin mediated diseases: dysregulation of an innate inflammatory pathway.Adv Immunol. 2014;121:41-89. doi: 10.1016/B978-0-12-800100-4.00002-7. Adv Immunol. 2014. PMID: 24388213 Review.
Cited by
-
Proteolytic inactivation of plasma C1- inhibitor in sepsis.J Clin Invest. 1989 Aug;84(2):443-50. doi: 10.1172/JCI114185. J Clin Invest. 1989. PMID: 2668333 Free PMC article.
-
Unique C1 inhibitor dysfunction in a kindred without angioedema. II. Identification of an Ala443-->Val substitution and functional analysis of the recombinant mutant protein.J Clin Invest. 1995 Mar;95(3):1299-305. doi: 10.1172/JCI117780. J Clin Invest. 1995. PMID: 7883978 Free PMC article.
-
Recombinant C1 inhibitor P5/P3 variants display resistance to catalytic inactivation by stimulated neutrophils.J Clin Invest. 1993 Mar;91(3):1035-43. doi: 10.1172/JCI116260. J Clin Invest. 1993. PMID: 8450033 Free PMC article.
-
Therapeutic approaches in hereditary angioedema.Clin Rev Allergy Immunol. 2011 Aug;41(1):114-22. doi: 10.1007/s12016-011-8254-2. Clin Rev Allergy Immunol. 2011. PMID: 21279474 Review.
-
Hereditary and acquired angioedema: problems and progress: proceedings of the third C1 esterase inhibitor deficiency workshop and beyond.J Allergy Clin Immunol. 2004 Sep;114(3 Suppl):S51-131. doi: 10.1016/j.jaci.2004.06.047. J Allergy Clin Immunol. 2004. PMID: 15356535 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous